Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1082 results for "pharma trading company"

The Rise, Fall And Steep Climb Of Aquinox Pharma...
RTTNews.com

The Rise, Fall And Steep Climb Of Aquinox Pharma...

Shares of Aquinox Pharmaceuticals Inc. (AQXP) have been red-hot in the last two trading days, up an eye-popping 3014%. When we profiled Aquinox on October 15, 2014, the stock was trading around $6. With not much change in the stock price, Aquinox ... RTTNews.com, 3 weeks ago
[x]  
NDTV Profit

Pharma stocks in focus

Shares of pharmaceutical companies will be in focus after the Ministry of Chemicals and Fertilizers after trading hours yesterday, 22 June 2015, said that a Task Force on the pharmaceutical sector has recommended measures to enhance regulatory support, ...
 Business Standard2 months ago Live: Sensex Likely to Fall on Global Cues; Sun Pharma to be in Focus  NDTV Profit3 weeks ago Live: Sensex Likely to Edge Lower on Global Cues; Sun Pharma to be in Focus  NDTV Profit3 weeks ago
TeleTrader.com

SPARC licenses Xelpros to Sun Pharmaceutical for US market, shares up 5%

At 9.55 am, share price of Sun Pharma Advanced Research Company was trading at Rs 426.50, up 5.01 per cent against its previous close.
 Money Today2 months ago La Jolla Pharma ignores market's plunge; shares up 19%  TeleTrader.com1 week ago
Schaeffers Research

Buzz Stocks: J C Penney Company Inc, WuXi PharmaTech (Cayman) Inc., and Tesla Motors Inc

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie ...
 Schaeffers Research2 weeks ago Biotech Stocks Is It Still Worthwhile Trading? Amgen, Inc. (NASDAQ:AMGN), PDL BioPharma Inc (NASDAQ:PDLI), Receptos Inc (NASDAQ:RCPT)  WS Observer.com4 weeks ago Antares Pharma Inc. (ATRS) Jumps 7.11% on July 31  Equities.com1 month ago
WKRB News

ZS Pharma Stock Price Down 7.6% Following Weak Earnings (ZSPH)

Shares of ZS Pharma (NASDAQ:ZSPH) traded down 7.6% during mid-day trading on Friday after the company announced weaker than expected quarterly earnings, Marketbeat.com reports. The stock traded as low as $53.78 and last traded at $55.42, with a ...
 WKRB News3 weeks ago ZS Pharma Shares Down 7.6% After Earnings Miss (ZSPH)  WKRB News3 weeks ago
Irish Times

Depomed confirms bid increase from Dublin-based Horizon

Horizon Pharma has told Depomed that it's prepared to increase its $2 billion offer for the company and include a cash component of as much as 25 per cent of the deal, according to Depomed chief executive Jim Schoeneck . The willingness to boost ...
 Irish Times3 weeks ago Horizon And DepoMed Are Great Buys With Or Without A Deal  Seeking Alpha21 hours ago Depomed Comments on Horizon Pharma Announcement  ADVFN India4 weeks ago Horizon Pharma : Depomed Comments on Horizon Pharma Announcement  4 Traders4 weeks ago
[x]  
Business Insider India

Shares of Sun Pharmaceutical Industries were among the top traded today. Know why

Futures of Sun Pharmaceutical Industries Ltd. were the top traded counter on the derivatives market after the company's unit, Taro Pharma, got the USFDA nod to sell Keveyis, a drug aimed at paralytic patients in the United States. The sale will ...
 Business Insider India2 weeks ago Big money and close ties behind Big Pharma's Brussels lobby efforts new study  Economic Voice1 hour ago Pharma industry backs govt's decision to defer trade talks with European Union  Economic Times3 weeks ago
NDTV Profit

Sun Pharma Rises 2% on Acquiring Opiates Business in Australia

Sun Pharma shares jumped nearly 2 per cent to hit intraday high of Rs 915.30 after the company said that it successfully acquired GSK's opiates facilities in Australia. Sun Pharma in an announcement said that it acquired GSK's two opiates ...
 NDTV Profit1 day ago Sun Pharma shares gain on completing acquisition of Opiates business in Australia  Financial Express1 day ago Sun Pharma completes acquisition of GSK Australia opiates business  Economic Times1 day ago Strides Arcolab, Shasun Pharma shares gain on HC nod for scheme of amalgamation  Financial Express5 days ago
[x]  
Financial Express

Dishman Pharma shares gain as company posts robust Q1 net profit figures

Dishman Pharmaceutical & Chemicals reported 58.55 per cent Year-on-Year (YoY) rise in a consolidated net profit figures for the quarter ended June 2015. (Photo: Reuters) Dishman Pharmaceutical & Chemicals shares jumped over 7 per cent intraday on ...
 Financial Express1 day ago Orchid Chemicals Pharma Q1 net loss at Rs 47.56 cr  Moneycontrol.com2 weeks ago Aurobindo Pharma's net profit rises 4.1% to Rs.432.4 crore  Livemint.com2 weeks ago GlaxoSmithKline Pharma slides after reporting dismal Q1 results  Capital Market4 weeks ago
NDTV Profit

Aurobindo Pharma surges in early trade

after the company said it has received the final approval from the US Food & Drug Administration to manufacture and market Raloxifene Hydrochloride Tablets USP 60mg. The announcement was made on Saturday, 29 August 2015. Meanwhile, the S BSE Sensex was down ...
 Business Standard2 days ago Aurobindo Gains on FDA Nod; Sun Pharma, Wockhardt Trade Mixed  NDTV Profit2 days ago Aurobindo Pharma shares gain over 3% on key drug approvals  Financial Express2 days ago Stock that are in focus today: Infosys, Sun Pharma and more  Financial Express2 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less